Clinical trial
Apixaban Discontinuation Prior to Major Surgery
NCT02935751 is registered in ClinicalTrials.gov with Thomas Jefferson University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Apixaban Discontinuation Prior to Major Surgery
- Lead sponsor
- Thomas Jefferson University
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2016
- Completion date
- September 30, 2018
- Enrollment
- 130 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.